Why Are Accolade Shares Down Over 40% Today

Loading...
Loading...
  • Accolade Inc ACCD shares plunged almost 50% after disappointing Q4 FY22 earnings and FY23 guidance.
  • Q4 FY22 revenue increased 58% Y/Y to $93.8 million, beating the consensus of $91.57 million.
  • The company reported a wider net loss of $(34.56) million compared to $(4.73) million a year ago.
  • EPS loss came at $(0.51) higher than the consensus of $(0.36).
  • Guidance: For Q1 FY23, Accolade expects revenues of $81 million - $83 million, below the consensus of $85.91 million.
  • It expects adjusted EBITDA loss of $(20) million - $(22) million.
  • For FY23, the company forecasts revenues of $350 million - $365 million, below the consensus of $387.39 million.
  • It expects adjusted EBITDA of $(35) million - $(40) million.
  • Credit Suisse has downgraded Accolade to Neutral and cut the price target to $9.
  • Morgan Stanley downgraded the stock to Equal-Weight, with a price target lowered to $9.
  • SVB Leerink too downgraded ACCD to Market Perform and lowered the price target to $8.
  • Needham maintains Buy on Accolade but cuts the price target to $12
  • Piper Sandler maintains Overweight with the price target slashed to $11
  • B of A Securities also downgraded Accolade to Neutral, with lowered price target to $9.
  • Price Action: ACCD shares are down 45% at $6.08 during the market session on the last check Friday.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceHealth CareSmall CapMoversTrading IdeasGeneralBriefswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...